Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03396913 · ClinicalTrials.gov registry record · NA
Effectiveness of Intense Pulsed Light for Improving Dry Eye Syndrome
A NA study, sponsored by Lumenis Be.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT03396913 is a NA study that has completed, run by Lumenis Be. The registered enrollment target is 88 participants.
The verdict
NCT03396913, a NA study, has completed, sponsored by Lumenis Be.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
The aim of the current study is to examine the contribution of intense pulsed light (IPL) for relieving signs and symptoms of dry eye due to meibomian gland dysfunction. The effect of IPL will be examined in a study designed as a randomized controlled trial. In the study arm, subjects will undergo 4 treatment sessions, consisting of IPL pulses immediately followed by meibomian gland expression (MGX). In the control arm, subjects will undergo the same treatments, except that the IPL pulses will be disabled. For each subject, the duration of the study will be 10 weeks, as explained in the detailed description.
Interventions
- DEVICE IPL
- DEVICE Sham IPL
- PROCEDURE MGX
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2018-01-10 |
| Est. Completion | 2019-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03396913
The ClinicalTrials.gov registry entry for NCT03396913 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumenis Be, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which IPL is the first listed.
NCT03396913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03396913 about?
NCT03396913 is a clinical study titled "Effectiveness of Intense Pulsed Light for Improving Dry Eye Syndrome". The aim of the current study is to examine the contribution of intense pulsed light (IPL) for relieving signs and symptoms of dry eye due to meibomian gland dysfunction. The effect of IPL will be examined in a study designed as a randomized controlled trial. In the study arm, subjects will undergo 4...
What is the current status of trial NCT03396913?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2018-01-10. Estimated completion is 2019-08-15.
What interventions are being tested in trial NCT03396913?
The interventions under investigation include: IPL (DEVICE), Sham IPL (DEVICE), MGX (PROCEDURE).
Who is sponsoring clinical trial NCT03396913?
This trial is sponsored by Lumenis Be, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.